Fundz

Alcresta Therapeutics, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $35 Million

PRIVATESep 25, 2017$10M of $35M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Sep 25, 2017)

Round Type

Venture

WalthamBiotechnologyHealth CareTherapeutics

Who to call at Alcresta Therapeutics, and when

A new round usually means Alcresta Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alcresta Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alcresta Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alcresta Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alcresta Therapeutics

Location

Waltham, Massachusetts, United States

About

Alcresta Therapeutics, Inc. is a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases. Recently, Alcresta announced 510(k) clearance of its next-generation RELiZORB® (iMMOBILIZED LIPASE) cartridge by the U.S. Food and Drug Administration (FDA), further solidifying its position in the market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alcresta Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts42 people are listed at Alcresta Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Alcresta Therapeutics's next move

See what Strategic adds

Alcresta Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.